• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于个性化给药的事件触发型智能双激素人工胰腺。

Event-triggered smart dual hormone artificial pancreas for patient-specific drug delivery.

作者信息

Govindaraju Divya, Subbian Sutha

机构信息

Department of Instrumentation Engineering, MIT Campus, Anna University, Chennai, 600044, Tamil Nadu, India.

出版信息

Sci Rep. 2025 Sep 1;15(1):32045. doi: 10.1038/s41598-025-18085-9.

DOI:10.1038/s41598-025-18085-9
PMID:40890467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12402495/
Abstract

Diabetes is a chronic disorder that disrupts the body's ability to regulate blood glucose (BG) levels, leading to dangerous fluctuations such as hypoglycemia and hyperglycemia. In managing Type 1 Diabetes (T1D), the Dual Hormone Artificial Pancreas (DHAP) has emerged as a promising solution for maintaining optimal BG levels by administering both insulin and glucagon. However, the major challenges in DHAPs are slow dynamics in glucose sensing and delayed insulin absorption. In this paper, a Smart Dual Hormone Artificial Pancreas (SDHAP) with Event-triggered Feed-Back (FB)-Feed Forward (FF) control schemes are proposed to control the BG level of diabetic individuals and reject external disturbance due to food intake or exercise. Firstly, the classification of blood glucose level was performed with features extracted from the T1DiabetesGranada dataset using Machine Learning (ML) algorithms like K-Nearest Neighbor (KNN) and Support Vector Machine (SVM), and BG levels were predicted using time-series analysis. Secondly, the Event -Triggered Proportional-Integral feedback controllers: Proportional Integral (PI) and Model Predictive Control are designed based on the Bergman Minimal Model (BMM) model to deliver appropriate hormones namely insulin/glucagon based on predicted results. Finally, the FF controller was designed to reject external disturbances under hypoglycemia and hyperglycemia conditions. The results show the proposed SDHAP is more effective in controlling blood glucose by delivering patient-specific drugs with appropriate dosages based on individualized pathological conditions of T1D patients.

摘要

糖尿病是一种慢性疾病,它会破坏人体调节血糖(BG)水平的能力,导致低血糖和高血糖等危险波动。在1型糖尿病(T1D)的管理中,双激素人工胰腺(DHAP)已成为一种有前景的解决方案,通过同时注射胰岛素和胰高血糖素来维持最佳血糖水平。然而,DHAP的主要挑战在于葡萄糖传感的动力学缓慢和胰岛素吸收延迟。本文提出了一种具有事件触发反馈(FB)-前馈(FF)控制方案的智能双激素人工胰腺(SDHAP),以控制糖尿病患者的血糖水平,并抵御因食物摄入或运动引起的外部干扰。首先,使用机器学习(ML)算法,如K近邻(KNN)和支持向量机(SVM),从T1DiabetesGranada数据集中提取特征来进行血糖水平分类,并使用时间序列分析来预测血糖水平。其次,基于伯格曼最小模型(BMM)设计事件触发比例积分反馈控制器:比例积分(PI)和模型预测控制,以便根据预测结果输送适当的激素,即胰岛素/胰高血糖素。最后,设计FF控制器以抵御低血糖和高血糖条件下的外部干扰。结果表明,所提出的SDHAP通过根据T1D患者的个体化病理状况提供适当剂量的个性化药物,在控制血糖方面更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/a46302d8a9d2/41598_2025_18085_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/8e21b6aca313/41598_2025_18085_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/89ded2783b04/41598_2025_18085_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/1dfe5268d41a/41598_2025_18085_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/61bd8186a21d/41598_2025_18085_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/8bbb14b775f6/41598_2025_18085_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/c0add378211e/41598_2025_18085_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/6cfa0adb1d92/41598_2025_18085_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/6aa82f6708ca/41598_2025_18085_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/3abef77893a6/41598_2025_18085_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/2ef29a9e4abd/41598_2025_18085_Fig30_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/0b937bc33f07/41598_2025_18085_Fig31_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/d97bd0211a38/41598_2025_18085_Fig32_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/eeb0549905b6/41598_2025_18085_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/b9258608776c/41598_2025_18085_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/3608827c6116/41598_2025_18085_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/d2389285e544/41598_2025_18085_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/a46302d8a9d2/41598_2025_18085_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/8e21b6aca313/41598_2025_18085_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/89ded2783b04/41598_2025_18085_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/1dfe5268d41a/41598_2025_18085_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/61bd8186a21d/41598_2025_18085_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/8bbb14b775f6/41598_2025_18085_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/c0add378211e/41598_2025_18085_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/6cfa0adb1d92/41598_2025_18085_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/6aa82f6708ca/41598_2025_18085_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/3abef77893a6/41598_2025_18085_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/2ef29a9e4abd/41598_2025_18085_Fig30_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/0b937bc33f07/41598_2025_18085_Fig31_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/d97bd0211a38/41598_2025_18085_Fig32_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/eeb0549905b6/41598_2025_18085_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/b9258608776c/41598_2025_18085_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/3608827c6116/41598_2025_18085_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/d2389285e544/41598_2025_18085_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011f/12402495/a46302d8a9d2/41598_2025_18085_Fig20_HTML.jpg

相似文献

1
Event-triggered smart dual hormone artificial pancreas for patient-specific drug delivery.用于个性化给药的事件触发型智能双激素人工胰腺。
Sci Rep. 2025 Sep 1;15(1):32045. doi: 10.1038/s41598-025-18085-9.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.1 型糖尿病中使用连续血糖监测和智能胰岛素笔进行长效胰岛素滴定:一种基于模型的无碳水化合物方法。
Front Endocrinol (Lausanne). 2022 Jan 10;12:795895. doi: 10.3389/fendo.2021.795895. eCollection 2021.
4
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
5
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法:一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.
6
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.自动胰岛素输送系统的研究空白、挑战与机遇
Diabetes Technol Ther. 2025 Jul;27(S3):S60-S71. doi: 10.1089/dia.2025.0129.
7
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.自动胰岛素输送系统的研究空白、挑战与机遇
J Diabetes Sci Technol. 2025 Jul;19(4):937-949. doi: 10.1177/19322968251338754. Epub 2025 Jul 1.
8
Glycaemic control in labour with diabetes: GILD, a scoping study.糖尿病产妇分娩期间的血糖控制:GILD,一项范围界定研究。
Health Technol Assess. 2025 Aug;29(41):1-150. doi: 10.3310/KHGD2761.
9
The effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review.胰岛素治疗方案对心脏手术后患者血糖水平的影响:一项系统评价。
JBI Database System Rev Implement Rep. 2015 Jun 12;13(5):205-43. doi: 10.11124/jbisrir-2015-1911.
10
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.

本文引用的文献

1
Artificial intelligence powered glucose monitoring and controlling system: Pumping module.人工智能驱动的血糖监测与控制系统:泵送模块。
World J Exp Med. 2024 Mar 20;14(1):87916. doi: 10.5493/wjem.v14.i1.87916.
2
Type 1 diabetes: from the dream of automated insulin delivery to a fully artificial pancreas.
Nat Med. 2024 May;30(5):1232-1234. doi: 10.1038/d41591-024-00013-5.
3
Global, regional, and national burden of type 1 diabetes in adolescents and young adults.全球、区域和国家青少年及青年1型糖尿病负担
Pediatr Res. 2025 Feb;97(2):568-576. doi: 10.1038/s41390-024-03107-5. Epub 2024 Mar 5.
4
T1DiabetesGranada: a longitudinal multi-modal dataset of type 1 diabetes mellitus.T1糖尿病格拉纳达研究:1型糖尿病的纵向多模态数据集。
Sci Data. 2023 Dec 20;10(1):916. doi: 10.1038/s41597-023-02737-4.
5
Artificial Intelligence and Machine Learning for Improving Glycemic Control in Diabetes: Best Practices, Pitfalls, and Opportunities.人工智能和机器学习在糖尿病血糖控制中的应用:最佳实践、陷阱和机遇。
IEEE Rev Biomed Eng. 2024;17:19-41. doi: 10.1109/RBME.2023.3331297. Epub 2024 Jan 12.
6
The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control.人工胰腺:实现全闭环系统并达到最佳血糖控制的两种替代方法。
J Endocrinol Invest. 2024 Mar;47(3):513-521. doi: 10.1007/s40618-023-02193-2. Epub 2023 Sep 15.
7
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022.16. 医院中的糖尿病护理:《糖尿病医学诊疗标准-2022》。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S244-S253. doi: 10.2337/dc22-S016.
8
Multi-step ahead predictive model for blood glucose concentrations of type-1 diabetic patients.1 型糖尿病患者血糖浓度的多步超前预测模型。
Sci Rep. 2021 Dec 21;11(1):24332. doi: 10.1038/s41598-021-03341-5.
9
Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.双激素人工胰腺治疗 1 型糖尿病:最新进展与未来方向。
Artif Organs. 2021 Sep;45(9):968-986. doi: 10.1111/aor.14023. Epub 2021 Jul 15.
10
Dual self-regulated delivery of insulin and glucagon by a hybrid patch.混合贴片的胰岛素和胰高血糖素双重自调节递送。
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29512-29517. doi: 10.1073/pnas.2011099117. Epub 2020 Nov 11.